English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and degrades NMNAT2

MPS-Authors

Evans,  Paul R.
Max Planck Florida Institute for Neuroscience, Max Planck Society;

Yasuda,  Ryohei
Max Planck Florida Institute for Neuroscience, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Desbois, M., Crawley, O., Evans, P. R., Baker, S. T., Masuho, I., Yasuda, R., et al. (2018). PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and degrades NMNAT2. Journal of Biological Chemistry, jbc.RA118.002176-ff. Retrieved from http://www.jbc.org/content/early/2018/07/11/jbc.RA118.002176.


Cite as: https://hdl.handle.net/21.11116/0000-0003-D50D-F
Abstract
PHR (PAM/Highwire/RPM-1) proteins are conserved RING E3 ubiquitin ligases that function in developmental processes, such as axon termination and synapse formation, as well as axon degeneration. At present, our understanding of how PHR proteins form ubiquitin ligase complexes remains incomplete. While genetic studies indicate NMNAT2 is an important mediator of PHR protein function in axon degeneration, it remains unknown how PHR proteins inhibit NMNAT2. Here, we decipher the biochemical basis for how the human PHR protein PAM, also called MYCBP2, forms a non-canonical Skp/Cullin/F-box (SCF) complex which contains the F-box protein FBXO45 and SKP1, but lacks CUL1. We show FBXO45 does not simply function in substrate recognition, but is important for assembly of the PAM/FBXO45/SKP1 complex. Interestingly, we demonstrate a novel role for SKP1 as an auxiliary component of the target recognition module that enhances binding of FBXO45 to NMNAT2. Finally, we provide biochemical evidence that PAM polyubiquitinates NMNAT2, and regulates NMNAT2 protein stability and degradation by the proteasome.